ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
2.300
-0.050 (-2.13%)
At close: Mar 6, 2026, 4:00 PM EST
2.290
-0.010 (-0.43%)
After-hours: Mar 6, 2026, 7:17 PM EST
ProKidney Market Cap
ProKidney has a market cap or net worth of $691.92 million as of March 6, 2026. Its market cap has increased by 56.08% in one year.
Market Cap
691.92M
Enterprise Value
424.43M
1-Year Change
56.08%
Ranking
Category
Stock Price
$2.30
Market Cap Chart
Since June 30, 2021, ProKidney's market cap has increased from $258.80M to $691.92M, an increase of 167.36%. That is a compound annual growth rate of 23.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 691.90M | 2.67% |
| Dec 31, 2025 | 673.90M | 36.72% |
| Dec 31, 2024 | 492.90M | 17.61% |
| Dec 29, 2023 | 419.10M | -73.75% |
| Dec 30, 2022 | 1.60B | 405.76% |
| Dec 31, 2021 | 315.70M | 21.99% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 738.16M |
| Lexicon Pharmaceuticals | 730.31M |
| Prime Medicine | 710.09M |
| Gyre Therapeutics | 700.76M |
| Jade Biosciences | 692.89M |
| Theravance Biopharma | 687.62M |
| Tectonic Therapeutic | 673.52M |
| MiMedx Group | 668.55M |